Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 140

1.

Clinical characteristics during diagnosis of a prospective cohort of patients with systemic lupus erythematosus treated in Spanish Departments of Internal Medicine: The RELES study.

Canora J, García M, Mitjavila F, Espinosa G, Suárez S, González-León R, Sopeña B, Boldova R, Castro A, Ruiz-Irastorza G; en representación de los investigadores del Registro RELES-Grupo de Enfermedades Autoinmunes Sistémicas (GEAS)..

Rev Clin Esp. 2016 Oct 25. pii: S0014-2565(16)30151-5. doi: 10.1016/j.rce.2016.09.006. [Epub ahead of print] English, Spanish.

PMID:
27793331
2.

Breast cancer in systemic lupus.

Bernatsky S, Ramsey-Goldman R, Petri M, Urowitz MB, Gladman DD, Fortin PF, Ginzler E, Romero-Diaz J, Peschken C, Jacobsen S, Hanly JG, Gordon C, Nived O, Yelin EH, Isenberg D, Rahman A, Bae SC, Joseph L, Witte T, Ruiz-Irastorza G, Aranow C, Kamen D, Sturfeldt G, Foulkes WD, Hansen JE, St Pierre Y, Raymer PC, Tessier-Cloutier B, Clarke AE.

Lupus. 2016 Sep 29. pii: 0961203316664595. [Epub ahead of print]

PMID:
27687028
3.

Off-label use of rituximab for systemic lupus erythematosus in Europe.

Rydén-Aulin M, Boumpas D, Bultink I, Callejas Rubio JL, Caminal-Montero L, Castro A, Colodro Ruiz A, Doria A, Dörner T, Gonzalez-Echavarri C, Gremese E, Houssiau FA, Huizinga T, Inanç M, Isenberg D, Iuliano A, Jacobsen S, Jimenéz-Alonso J, Kovács L, Mariette X, Mosca M, Nived O, Oristrell J, Ramos-Casals M, Rascón J, Ruiz-Irastorza G, Sáez-Comet L, Salvador Cervelló G, Sebastiani GD, Squatrito D, Szücs G, Voskuyl A, van Vollenhoven R.

Lupus Sci Med. 2016 Sep 6;3(1):e000163. doi: 10.1136/lupus-2016-000163.

4.

Prevalence and predictors of valvular heart disease in patients with systemic lupus erythematosus.

Vivero F, Gonzalez-Echavarri C, Ruiz-Estevez B, Maderuelo I, Ruiz-Irastorza G.

Autoimmun Rev. 2016 Dec;15(12):1134-1140. doi: 10.1016/j.autrev.2016.09.007. Review.

PMID:
27639157
5.

First month prednisone dose predicts prednisone burden during the following 11 months: an observational study from the RELES cohort.

Ruiz-Irastorza G, Garcia M, Espinosa G, Caminal L, Mitjavila F, González-León R, Sopeña B, Canora J, Villalba MV, Rodríguez-Carballeira M, López-Dupla JM, Callejas JL, Castro A, Tolosa C, Sánchez-García ME, Pérez-Conesa M, Navarrete-Navarrete N, Rodríguez AP, Herranz MT, Pallarés L.

Lupus Sci Med. 2016 Aug 2;3(1):e000153. doi: 10.1136/lupus-2016-000153.

6.

Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study.

Amengual O, Forastiero R, Sugiura-Ogasawara M, Otomo K, Oku K, Favas C, Delgado Alves J, Žigon P, Ambrožič A, Tomšič M, Ruiz-Arruza I, Ruiz-Irastorza G, Bertolaccini ML, Norman GL, Shums Z, Arai J, Murashima A, Tebo AE, Gerosa M, Meroni PL, Rodriguez-Pintó I, Cervera R, Swadzba J, Musial J, Atsumi T.

Lupus. 2016 Aug 10. pii: 0961203316660203. [Epub ahead of print]

PMID:
27510605
7.

SLE: the changing prognosis.

Ugarte A, Ruiz-Irastorza G.

Lupus. 2016 Oct;25(12):1285-7. doi: 10.1177/0961203316652948.

PMID:
27307448
8.

Systemic lupus erythematosus.

Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, Ruiz-Irastorza G, Hughes G.

Nat Rev Dis Primers. 2016 Jun 16;2:16039. doi: 10.1038/nrdp.2016.39.

PMID:
27306639
9.

[Pregnancy in systemic autoimmune diseases: Myths, certainties and doubts].

Danza Á, Ruiz-Irastorza G, Khamashta M.

Med Clin (Barc). 2016 Oct 7;147(7):306-12. doi: 10.1016/j.medcli.2016.03.019. Review. Spanish.

PMID:
27143525
10.

Cardiovascular events prior to or early after diagnosis of systemic lupus erythematosus in the systemic lupus international collaborating clinics cohort.

Urowitz MB, Gladman DD, Anderson NM, Su J, Romero-Diaz J, Bae SC, Fortin PR, Sanchez-Guerrero J, Clarke A, Bernatsky S, Gordon C, Hanly JG, Wallace DJ, Isenberg D, Rahman A, Merrill J, Ginzler E, Alarcón GS, Fessler BF, Petri M, Bruce IN, Khamashta M, Aranow C, Dooley M, Manzi S, Ramsey-Goldman R, Sturfelt G, Nived O, Steinsson K, Zoma A, Ruiz-Irastorza G, Lim S, Kalunian KC, Ỉnanç M, van Vollenhoven R, Ramos-Casals M, Kamen DL, Jacobsen S, Peschken C, Askanase A, Stoll T.

Lupus Sci Med. 2016 Apr 12;3(1):e000143. doi: 10.1136/lupus-2015-000143. Erratum in: Lupus Sci Med. 2016;3(1):e000143corr1.

11.

[Hydroxychloroquine for autoimmune diseases].

Danza Á, Graña D, Goñi M, Vargas A, Ruiz-Irastorza G.

Rev Med Chil. 2016 Feb;144(2):232-40. doi: 10.4067/S0034-98872016000200012. Review. Spanish.

12.

Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?

Legault KJ, Ugarte A, Crowther MA, Ruiz-Irastorza G.

Curr Rheumatol Rep. 2016 May;18(5):26. doi: 10.1007/s11926-016-0573-0. Review.

PMID:
27032789
13.

A Longitudinal Analysis of Outcomes of Lupus Nephritis in an International Inception Cohort Using a Multistate Model Approach.

Hanly JG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Petri M, Bruce IN, Dooley MA, Fortin P, Gladman DD, Sanchez-Guerrero J, Steinsson K, Ramsey-Goldman R, Khamashta MA, Aranow C, Alarcón GS, Fessler BJ, Manzi S, Nived O, Sturfelt GK, Zoma AA, van Vollenhoven RF, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Kalunian KC, Inanc M, Kamen DL, Peschken CA, Jacobsen S, Askanase A, Theriault C, Farewell V.

Arthritis Rheumatol. 2016 Aug;68(8):1932-44. doi: 10.1002/art.39674.

PMID:
26991067
14.

[Clinical practice guidelines for systemic lupus erythematosus: Recommendations for general clinical management].

Trujillo-Martín MM, Rúa-Figueroa Fernández de Larrinoa I, Ruíz-Irastorza G, Pego-Reigosa JM, Sabio Sánchez JM, Serrano-Aguilar P; en nombre del Grupo Elaborador de la GPC-LES..

Med Clin (Barc). 2016 May 6;146(9):413.e1-14. doi: 10.1016/j.medcli.2016.01.013. Spanish.

PMID:
26975887
15.

Patterns of drug therapy in newly diagnosed Spanish patients with systemic lupus erythematosus.

Ruiz-Irastorza G, García M, Espinosa G, Cabezas-Rodríguez I, Mitjavila F, González-León R, Sopeña B, Perales I, Pinilla B, Rodríguez-Carballeira M, López-Dupla JM, Callejas JL, Castro A, Tolosa C, Sánchez-García ME, Pérez-Conesa M, Navarrete-Navarrete N, Rodríguez AP, Herranz MT, Pallarés L; RELES, Autoimmune Diseases Study Group GEAS..

Clin Exp Rheumatol. 2016 May-Jun;34(3):466-72.

PMID:
26940538
16.

The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.

Götestam Skorpen C, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, da Silva J, Nelson-Piercy C, Cetin I, Costedoat-Chalumeau N, Dolhain R, Förger F, Khamashta M, Ruiz-Irastorza G, Zink A, Vencovsky J, Cutolo M, Caeyers N, Zumbühl C, Østensen M.

Ann Rheum Dis. 2016 May;75(5):795-810. doi: 10.1136/annrheumdis-2015-208840.

17.

Rituximab-refractory lupus nephritis successfully treated with belimumab.

Gonzalez-Echavarri C, Ugarte A, Ruiz-Irastorza G.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2):355-6. No abstract available.

PMID:
26886714
18.

LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers.

Ochoa E, Iriondo M, Manzano C, Fullaondo A, Villar I, Ruiz-Irastorza G, Zubiaga AM, Estonba A.

PLoS One. 2016 Jan 28;11(1):e0146990. doi: 10.1371/journal.pone.0146990.

19.

The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment.

Sciascia S, Branch DW, Levy RA, Middeldorp S, Pavord S, Roccatello D, Ruiz-Irastorza G, Tincani A, Khamashta M, Schreiber K, Hunt BJ.

Thromb Haemost. 2016 Jan;115(2):285-90. doi: 10.1160/TH15-06-0491.

PMID:
26421409
20.

The frequency and outcome of lupus nephritis: results from an international inception cohort study.

Hanly JG, O'Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, Bae SC, Bernatsky S, Clarke AE, Wallace DJ, Merrill JT, Isenberg DA, Rahman A, Ginzler EM, Fortin P, Gladman DD, Sanchez-Guerrero J, Petri M, Bruce IN, Dooley MA, Ramsey-Goldman R, Aranow C, Alarcón GS, Fessler BJ, Steinsson K, Nived O, Sturfelt GK, Manzi S, Khamashta MA, van Vollenhoven RF, Zoma AA, Ramos-Casals M, Ruiz-Irastorza G, Lim SS, Stoll T, Inanc M, Kalunian KC, Kamen DL, Maddison P, Peschken CA, Jacobsen S, Askanase A, Theriault C, Thompson K, Farewell V.

Rheumatology (Oxford). 2016 Feb;55(2):252-62. doi: 10.1093/rheumatology/kev311.

Items per page

Supplemental Content

Loading ...
Support Center